Veterinary Medicines

Bovilis Ringvac <9 and >21 Lyophilisate+solvent for suspension for injection

Suspended
  • Trichophyton verrucosum, strain LTF-130, Live
Download as PDF

Product identification

Medicine name:
Bovilis Ringvac <9 and >21 Lyophilisate+solvent for suspension for injection
BOVILIS RINGVAC
Active substance:
  • Trichophyton verrucosum, strain LTF-130, Live
Target species:
  • Cattle
  • Cattle (calf)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Trichophyton verrucosum, strain LTF-130, Live
    21000000.00
    cells
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Cattle (calf)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AP01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Suspended
Authorised in:
  • France
Package description:
  • (ID2) 40 millilitre(s); 40 Dose: Box (Cardboard) with 1 Bottle (Glass) with 40 Dose and 1 Bottle (Glass) with 40 millilitre(s)
  • (ID1) 10 Dose; 10 millilitre(s): Box (Cardboard) with 1 Bottle (Glass) with 10 Dose and 1 Bottle (Glass) with 10 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet
Marketing authorisation date:
This information is not available for this product.
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/0595008 3/2005
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0231/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • France
  • Greece
  • Hungary
  • Ireland
  • Luxembourg
  • Poland
  • Portugal
  • Slovakia
  • Slovenia

Documents

Summary of Product Characteristics

English (PDF)
Published on: 14/02/2022
Download
French (PDF)
Published on: 4/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."